​

Immix Biopharma (IMMX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Immix Biopharma Revenue Highlights

00

Immix Biopharma Revenue by Period

Immix Biopharma Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$-89.52M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Immix Biopharma generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Immix Biopharma Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$96.29K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$4.78K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$-89.52M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Immix Biopharma generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Immix Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
COYACoya Therapeutics$3.55B$3.56B
MGNXMacroGenics$149.96M$22.24M
ZNTLZentalis Pharmaceuticals$67.42M-
WHWKWhitehawk Therapeutics$25.98M$7.24M
SRZNSurrozen$10.65M$983.00K
ORMPOramed Pharmaceuticals$1.34M-
IMMXImmix Biopharma--
ATOSAtossa Therapeutics--
TILInstil Bio--
PLRXPliant Therapeutics--
ONCYOncolytics Biotech--

IMMX Revenue FAQ

What is Immix Biopharma’s yearly revenue?

Immix Biopharma's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. IMMX's yearly revenue for 2022 was $-89.517M, representing an increase of 100.00% compared to 2021.

What is Immix Biopharma’s quarterly revenue?

Immix Biopharma's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). IMMX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Immix Biopharma’s revenue growth rate?

Immix Biopharma's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.